|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2004-9-8
|
|
pubmed:abstractText |
The aim of study was to examine the efficacy of reduced-dose alteplase plus abciximab versus alteplase alone by quantifying the amount of myocardium salvaged using myocardial scintigraphy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0929-5305
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
191-7
|
|
pubmed:dateRevised |
2005-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:15353917-Aged,
pubmed-meshheading:15353917-Antibodies, Monoclonal,
pubmed-meshheading:15353917-Drug Therapy, Combination,
pubmed-meshheading:15353917-Female,
pubmed-meshheading:15353917-Humans,
pubmed-meshheading:15353917-Immunoglobulin Fab Fragments,
pubmed-meshheading:15353917-Male,
pubmed-meshheading:15353917-Middle Aged,
pubmed-meshheading:15353917-Myocardial Infarction,
pubmed-meshheading:15353917-Myocardial Reperfusion,
pubmed-meshheading:15353917-Platelet Glycoprotein GPIIb-IIIa Complex,
pubmed-meshheading:15353917-Radionuclide Imaging,
pubmed-meshheading:15353917-Thrombolytic Therapy,
pubmed-meshheading:15353917-Time Factors,
pubmed-meshheading:15353917-Tissue Plasminogen Activator,
pubmed-meshheading:15353917-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Myocardial salvage after reduced-dose thrombolysis combined with glycoprotein IIb/IIIa blockade versus thrombolysis alone in patients with acute myocardial infarction.
|
|
pubmed:affiliation |
The Deutsches Herzzentrum, 80636 Munich, Germany. ndrepepa@dhm.mhn.de
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|
